BHC Valeant Pharmaceuticals: Company Short-Term Debts

Symbol and logo of brand Bausch Health (BHC)

Bausch Health Companies (BHC) competes in the dermatology and gastroenterology segments, seeking to reduce debt through asset sales. This chart on GURU.Markets reflects liquidity dynamics for the short-term debt portfolio, with the indicator holding around 0.00. Management aims to unlock business value by optimizing the corporate structure. The holding's resilience is based on a wide range of ophthalmological and cosmetic products.

bauschhealth.com (BHC) - Company Short-Term Loans and Borrowings from 07/04/2022 to 10/30/2026

Analytical breakdowns and data insights for company Bausch Health Corp (BHC)

- current quotes and average value forecast:
Price Chart Bausch Health|BHC - Consensus Target
- company stock capitalization data:
Market Capitalization Bausch Health Companies Inc.|BHC - Enterprise Value
- business book valuation details:
Accounting Value per Share Bausch Health|BHC - Accounting Value of Company|Market Capitalization to Book Value Ratio bauschhealth.com|BHC - Aggregate Asset Value
- debt level and financial liquidity data:
Debt to Equity Bausch Health Companies|BHC - Long-Term Liabilities to Capital|Short-Term Debt to Equity Bausch Health Companies|BHC - Company Debts|Debts to Book Capitalization Bausch Health Companies Inc.|BHC - Company Long-Term Indebtedness|Company Short-Term Debts Bausch Health|Quick Liquidity bauschhealth.com
- earnings and valuation multiples indicators:
BHC - Company Profit
Fundamental company valuation:Bausch Health (BHC)
Mass-produced product of Bausch Health Companies

Steady demand for Bausch Health Companies (BHC) ophthalmology solutions ensures a consistent cash flow to service obligations. By analyzing short-term borrowings due within one year, an investor assesses the aggregate of loans and bonds maturing within twelve months, which allows for the determination of liquidity risk and the impact of current payments on free cash flow and the holding's overall financial stability.

Direct competitors

LLY - Company Short-Term Debt|AbbVie Inc (ABBV) - Company Current Liabilities|AZN: Company Short-Term Debts|Novartis Pharma (NVS) - Company Short-Term Debts|Company Current Liabilities MRK|NVO: Company Short-Term Loans and Borrowings|Company Short-Term Debts AMGN|PFE (Pfizer Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Sanofi Aventis SNY|Bristol-Myers Squibb Co. (BMY) - Short-Term Debt|GSK - Company Short-Term Debt|TAK: Company Short-Term Debt|TEVA: Company Short-Term Debts|Company Short-Term Indebtedness RDY|VTRS (Viatris Corp) - Company Short-Term Debts|Roivant Corp (ROIV) - Short-Term Debt Volume|Company Short-Term Debt Zai Lab Limited (ZLAB)|cosmosholdingsinc.com - Company Short-Term Indebtedness